Matches in Wikidata for { <http://www.wikidata.org/entity/Q91227322> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q91227322 description "artículu científicu espublizáu en setiembre de 2019" @default.
- Q91227322 description "scientific article published on 16 September 2019" @default.
- Q91227322 description "wetenschappelijk artikel" @default.
- Q91227322 description "наукова стаття, опублікована 16 вересня 2019" @default.
- Q91227322 name "A phase 2 study of lenvatinib in patients with RET fusion-positive lung adenocarcinoma" @default.
- Q91227322 name "A phase 2 study of lenvatinib in patients with RET fusion-positive lung adenocarcinoma" @default.
- Q91227322 type Item @default.
- Q91227322 label "A phase 2 study of lenvatinib in patients with RET fusion-positive lung adenocarcinoma" @default.
- Q91227322 label "A phase 2 study of lenvatinib in patients with RET fusion-positive lung adenocarcinoma" @default.
- Q91227322 prefLabel "A phase 2 study of lenvatinib in patients with RET fusion-positive lung adenocarcinoma" @default.
- Q91227322 prefLabel "A phase 2 study of lenvatinib in patients with RET fusion-positive lung adenocarcinoma" @default.
- Q91227322 P1433 Q91227322-7E71A8FE-18CD-4C7C-BD9D-7DFD0E9FF1A2 @default.
- Q91227322 P1476 Q91227322-A24B8FB1-2509-41D0-BDA8-EFDB63CA4554 @default.
- Q91227322 P2093 Q91227322-05F5E69A-3143-4925-800C-A922F0CF9BD8 @default.
- Q91227322 P2093 Q91227322-313A75E7-4677-4CEE-8E9A-2001B9C74902 @default.
- Q91227322 P2093 Q91227322-5909B86E-06ED-4928-BBB3-E1E13FB72D91 @default.
- Q91227322 P2093 Q91227322-7C715EA8-476D-402B-9AEA-788E24BA3A12 @default.
- Q91227322 P2093 Q91227322-8A2367A5-2639-49B0-A373-CC1260C6BF16 @default.
- Q91227322 P2093 Q91227322-8EB0C3AA-D4B5-460D-B82C-741A763D2FD0 @default.
- Q91227322 P2093 Q91227322-A3D9F21C-0033-4A38-8863-500D9EDEA1E8 @default.
- Q91227322 P2093 Q91227322-B3C08A0D-CDBB-4FC0-9994-CA51611BE47A @default.
- Q91227322 P2093 Q91227322-CFDF7860-46BB-4B5D-B827-3ABFD5FFEC01 @default.
- Q91227322 P2093 Q91227322-E07FF208-FF33-49A1-AA26-E49843D7E6B4 @default.
- Q91227322 P304 Q91227322-6171186F-AEF8-49C6-B761-607D0DEDA4A0 @default.
- Q91227322 P31 Q91227322-DAA82875-6EED-4A9C-BF7C-BB265299C025 @default.
- Q91227322 P356 Q91227322-5FBE58BF-1542-4300-94B1-8F0031A573F1 @default.
- Q91227322 P478 Q91227322-132DC137-2806-4287-940E-B2B2E7CF6895 @default.
- Q91227322 P577 Q91227322-D467E3F2-F6CF-4963-902D-02FBE0E7D932 @default.
- Q91227322 P698 Q91227322-23442D0E-5873-4486-8935-0EF1250ED428 @default.
- Q91227322 P921 Q91227322-8C1F11FE-C5B5-4F70-9659-413256E1DC3E @default.
- Q91227322 P356 J.LUNGCAN.2019.09.011 @default.
- Q91227322 P698 31710864 @default.
- Q91227322 P1433 Q641464 @default.
- Q91227322 P1476 "A phase 2 study of lenvatinib in patients with RET fusion-positive lung adenocarcinoma" @default.
- Q91227322 P2093 "Corina E Dutcus" @default.
- Q91227322 P2093 "Hiroshi Nokihara" @default.
- Q91227322 P2093 "Karen L Reckamp" @default.
- Q91227322 P2093 "Min Ren" @default.
- Q91227322 P2093 "Pallavi Sachdev" @default.
- Q91227322 P2093 "Takuya Nakada" @default.
- Q91227322 P2093 "Tomohide Tamura" @default.
- Q91227322 P2093 "Tomoki Kubota" @default.
- Q91227322 P2093 "Toyoaki Hida" @default.
- Q91227322 P2093 "Vamsidhar Velcheti" @default.
- Q91227322 P304 "124-130" @default.
- Q91227322 P31 Q13442814 @default.
- Q91227322 P356 "10.1016/J.LUNGCAN.2019.09.011" @default.
- Q91227322 P478 "138" @default.
- Q91227322 P577 "2019-09-16T00:00:00Z" @default.
- Q91227322 P698 "31710864" @default.
- Q91227322 P921 Q356033 @default.